ES369337A1 - Procedimiento para la fabricacion de nuevos medicamentos antiespasmodicos, antiarritmicos, antipireticos y antimala- ricos de accion prolongada. - Google Patents

Procedimiento para la fabricacion de nuevos medicamentos antiespasmodicos, antiarritmicos, antipireticos y antimala- ricos de accion prolongada.

Info

Publication number
ES369337A1
ES369337A1 ES369337A ES369337A ES369337A1 ES 369337 A1 ES369337 A1 ES 369337A1 ES 369337 A ES369337 A ES 369337A ES 369337 A ES369337 A ES 369337A ES 369337 A1 ES369337 A1 ES 369337A1
Authority
ES
Spain
Prior art keywords
sulphate
antipathytic
antimalaric
antispasmodic
antiarrhythmic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES369337A
Other languages
English (en)
Spanish (es)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
RECH APPLIC SOC GEN DE
Original Assignee
RECH APPLIC SOC GEN DE
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by RECH APPLIC SOC GEN DE filed Critical RECH APPLIC SOC GEN DE
Publication of ES369337A1 publication Critical patent/ES369337A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
    • C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems
    • C07D453/04—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems having a quinolyl-4, a substituted quinolyl-4 or a alkylenedioxy-quinolyl-4 radical linked through only one carbon atom, attached in position 2, e.g. quinine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/61—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule the organic macromolecular compound being a polysaccharide or a derivative thereof

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ES369337A 1968-07-18 1969-07-09 Procedimiento para la fabricacion de nuevos medicamentos antiespasmodicos, antiarritmicos, antipireticos y antimala- ricos de accion prolongada. Expired ES369337A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB3438268 1968-07-18

Publications (1)

Publication Number Publication Date
ES369337A1 true ES369337A1 (es) 1971-06-01

Family

ID=10364956

Family Applications (1)

Application Number Title Priority Date Filing Date
ES369337A Expired ES369337A1 (es) 1968-07-18 1969-07-09 Procedimiento para la fabricacion de nuevos medicamentos antiespasmodicos, antiarritmicos, antipireticos y antimala- ricos de accion prolongada.

Country Status (8)

Country Link
BE (1) BE735129A (nl)
CH (1) CH502386A (nl)
DE (1) DE1936723C2 (nl)
ES (1) ES369337A1 (nl)
FR (1) FR2013170A1 (nl)
GB (1) GB1227830A (nl)
NL (1) NL149808B (nl)
OA (1) OA03630A (nl)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1294538A (en) * 1970-04-30 1972-11-01 Rech S Et D Applic Scient Soge Pharmaceutical compositions
FR2201898A1 (en) * 1973-05-30 1974-05-03 Sogeras Vincamine arabogalactan sulphate - with prolonged activity for treating cerebrovascular disorders
US6077822A (en) * 1993-09-14 2000-06-20 Dumex-Alpharma A/S Drug salts
ES2142407T3 (es) * 1993-09-20 2000-04-16 Ajinomoto Kk Antimalaria.
DE69504973T2 (de) * 1994-06-10 1999-02-18 Dumex Ltd As Salze von medikamenten

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1143204B (de) * 1958-08-05 1963-02-07 Mundipharma Ag Verfahren zur Herstellung von Chinidingalacturonat und Chinidinpolygalacturonat
DE1218457B (de) * 1961-10-10 1966-06-08 Mundipharma Ag Verfahren zur Herstellung von Dihydrochinidingalakturonat und Dihydrochinidinpolygalakturonat

Also Published As

Publication number Publication date
GB1227830A (nl) 1971-04-07
DE1936723C2 (de) 1983-12-22
NL149808B (nl) 1976-06-15
DE1936723A1 (de) 1970-05-14
CH502386A (fr) 1971-01-31
FR2013170A1 (nl) 1970-03-27
NL6910987A (nl) 1970-01-20
BE735129A (nl) 1969-12-01
OA03630A (fr) 1971-12-24

Similar Documents

Publication Publication Date Title
BR7206635D0 (pt) Aperfeicoado cigarro ventilado com ponta filtrante
ES369337A1 (es) Procedimiento para la fabricacion de nuevos medicamentos antiespasmodicos, antiarritmicos, antipireticos y antimala- ricos de accion prolongada.
GB1094876A (en) Process for producing the trans-stereoisomer of 4-aminomethylcyclohexane-1-carboxylic acid and salts thereof
AU511347B2 (en) Quinuclidine derivatives with pharmaceutical properties
NL181825C (nl) Groeftasterarm en werkwijze voor de vervaardiging hiervan.
FR3271M (fr) N-alkyl- et n-arylalkyl-benzoxacycloalkaneméthylamines comme analgésiques et hypotenseurs.
PH11413A (en) Process and intermediates for quinine,quinidine and derivatives thereof
IL40623A0 (en) New eburnamine-type alkaloids and salts thereof,their preparation and pharmaceutical compositions containing them
IL39381A0 (en) Rheadan-type alkaloids,their preparation and pharmaceutical compositions containing them
ES386714A1 (es) Procedimiento para la preparacion de nuevos derivados de tiepina.
SE398128B (sv) Slaggbildande emne for stalframstellning
ES375563A1 (es) Procedimiento de fabricacion semisintetica de sales de fla-vilio.
ES208132U (es) Envase perfeccionado.
ES294357A1 (es) Procedimiento para la obtención de nuevos nonapepturos
ES218247U (es) Expositor.
PH9794A (en) Process for the manufacture of quinine,quinidine and analogs thereof
CA873893A (en) Cinchona alkaloid derivatives
ES401511A1 (es) Procedimiento para la preparacion de tripeptidos.
ES326754A1 (es) Un procedimiento para preparar 2-metoxi-4-(n4-glutaril-sulfamilamido) quinazolina y sus sales metalicas farmaceuticamente aceptables.
ES213380U (es) Un recipiente para bebidas perfeccionado.
ES431345A2 (es) Doble grua giratoria.
ES419868A1 (es) Procedimiento para la preparacion de un complejo de codeinay 6-amino-2-metil-heptan-2-ol.
CA815894A (en) Manufacture of points for ball point pens
ES323505A1 (es) Procedimiento para la obtencion de 1,2-difenil-2-propioniloxi-3-(dimetilaminometil)-3-buteno.
ES405154A3 (es) Procedimiento para la obtencion de acido 3, 4, 5 trimetoxi-benzoilamidocarboxilico y sus sales.